Berkeley Doctor Describes Why People Die From Chemotherapy, Not Cancer, and Cancer Researchers Discover How High-Dose Vitamin C Kills Cancer Cells
People who refuse chemotherapy treatment live on average 12 and a half years longer than people who undergo chemotherapy, says Dr. Jones.
According to recent statistics, approximately 1 in 2 men and 1 in 3 women will develop cancer in their lifetimes.
Related: The FDA Controlled By Big Parma Since Gov’t. Deal In 90’s
This saddening reality is made worse when it is acknowledged that modern methods of ‘treating’ the disease are often ineffective and only make the symptoms of the disease worse. In fact, according to one Berkeley doctor, chemotherapy doesn’t work 97% of the time.
In the eye-opening video above, Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, discusses how ‘leading edge’ cancer treatment is a sham.
He has personally studied the life expectancy of patients for more than 25 years and has come to the conclusion that chemotherapy does more harm than good. The bone-chilling realization prompted Dr. Jones to speak out against the billion-dollar cancer industry.
“People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy,” said Dr. Jones of his study, which was published in the New York Academy of Science.
|“People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.”|
According to the physician, the only reason doctors prescribe chemotherapy is because they make money from it. Such an accusation doesn’t seem unreasonable, as cancer treatment runs, on average, between $300,000 – $1,000,000 per treatment.
|“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. So this is something that you will not hear in the mass media, which will continue to carry the myth that the best chemotherapy drug in the fight against cancer!”|
Despite the fact that the United States spends more on healthcare than any other high-income nation in the world, diseases of affluence continue to increase in prevalence, resulting in a shorter life expectancy.
Perhaps this is because mainstream media and the allopathic healthcare system don’t teach about the importance of preventative medicine. Eating a healthy diet, engaging in exercise, thinking positive thoughts, reducing stress, and enjoying the company of others – or habits that bring joy – are all proven to improve longevity and happiness.
Related: Nebulizing Sodium Bicarbonate
In addition, potent all natural medicines, such as cannabis oil, are also strictly regulated and illegal in many areas – despite the fact that CBD-rich oil from the marijuana plant is listed as a remedy on the U.S.’ National Cancer Institute’s website.
As it is, there is no money in a healthy population, which is why fast food joints and pharmaceutical industries thrive in America. Hopefully, Dr. Jones’ efforts will inspire people to seek out alternative options if they or someone they know develops the debilitating disease.
In 2004, the Journal of Clinical Oncology published a study about chemotherapy’s success rates when looking at how many cancer patients were still alive after 5 years. It states:
RESULTS: The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.
CONCLUSION: As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.
You’d be hard pressed to find anything still being touted as your best shot at a cure with an average success rate of just over 2 percent, which chemotherapy has, if it wasn’t for the fact that big profits were driving the recommendation. For stage 4 cancers the rate is less than half of one percent.
Fundamentally, chemotherapy rarely works. Worse, some drug treatments also promote the spread of cancer. But somehow the rationale to avoid these agents because they might promote cancer does not apply when it comes to drugs. –
A Cancer Journal for the Clinician article concludes by stating:
|“Pending the publication of suitable trials, clinicians must be guided by existing data in the context of a fundamental principle of medicine, “Primum non nocere.” (First do no harm.)”|
And yet, conventional cancer treatments can in no way, shape or form ever be considered harmless.
|“As a chemist trained to interpret data, it is incomprehensible to me that physicians can ignore the clear evidence that chemotherapy does much, much more harm than good.”
– Alan C Nixon, PhD, former president of the American Chemical Society
Cancer Researchers Discover How High-Dose Vitamin Kills Cancer Cells
Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.
Most vitamin C therapies involve taking the substance orally. However, the UI scientists have shown that giving vitamin C intravenously – and bypassing normal gut metabolism and excretion pathways – creates blood levels that are 100 – 500 times higher than levels seen with oral ingestion.
It is this super-high concentration in the blood that is crucial to vitamin C’s ability to attack cancer cells.
Earlier work by UI redox biology expert Garry Buettner found that at these extremely high levels (in the millimolar range), vitamin C selectively kills cancer cells but not normal cells in the test tube and in mice.
Physicians at UI Hospitals and Clinics are now testing the approach in clinical trials for pancreatic cancer and lung cancer that combine high-dose, intravenous vitamin C with standard chemotherapy or radiation.
Not quite how it’s done
Earlier phase 1 trials indicated this treatment is safe and well-tolerated and hinted that the therapy improves patient outcomes. The current, larger trials aim to determine if the treatment improves survival.
In a new study, published recently in the December issue of the journal Redox Biology, Buettner and his colleagues have homed in on the biological details of how high-dose vitamin C (also known as ascorbate) kills cancer cells.
The study shows that vitamin C breaks down easily, generating hydrogen peroxide, a so-called reactive oxygen species that can damage tissue and DNA. The study also shows that tumor cells are much less capable of removing the damaging hydrogen peroxide than normal cells.
|“In this paper we demonstrate that cancer cells are much less efficient in removing hydrogen peroxide than normal cells. Thus, cancer cells are much more prone to damage and death from a high amount of hydrogen peroxide,” says Buettner, a professor of radiation oncology and a member of Holden Comprehensive Cancer Center at the University of Iowa.
“This explains how the very, very high levels of vitamin C used in our clinical trials do not affect normal tissue, but can be damaging to tumor tissue.”
Normal cells have several ways to remove hydrogen peroxide, keeping it at very low levels so it does not cause damage. The new study shows that an enzyme called catalase is the central route for removing hydrogen peroxide generated by decomposing vitamin C.
The researchers discovered that cells with lower amounts of catalase activity were more susceptible to damage and death when they were exposed to high amounts of vitamin C.
Buettner says this fundamental information might help determine which cancers and which therapies could be improved by inclusion of high-dose ascorbate in the treatment.
|“Our results suggest that cancers with low levels of catalase are likely to be the most responsive to high-dose vitamin C therapy, whereas cancers with relatively high levels of catalase may be the least responsive,” he explains.
A future goal of the research is to develop methods to measure catalase levels in tumors.
Journal Reference: Claire M. Doskey, Visarut Buranasudja, Brett A. Wagner, Justin G. Wilkes, Juan Du, Joseph J. Cullen, Garry R. Buettner. Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy. Redox Biology, 2016; 10: 274
Comment: Intravenous vitamin C does more than just kill cancer cells. It boosts immunity and can stimulate collagen formation to help the body wall off the tumor. It inhibits hyaluronidase, an enzyme that tumors use to metastasize and invade other organs throughout the body and corrects the almost universal scurvy in cancer patients.